- Home
- TXRH vs ELAN Comparison
TXRH vs ELAN Comparison
Compare TXRH & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TXRH | ELAN |
|---|---|---|
| Founded | 1993 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7B | 10.3B |
| IPO Year | 2004 | 2018 |
Fundamental Metrics
Financial Performance| Metric | TXRH | ELAN |
|---|---|---|
| Price | $170.89 | $22.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 9 |
| Target Price | ★ $189.47 | $21.13 |
| AVG Volume (30 Days) | 1.2M | ★ 5.6M |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | ★ 1.59% | N/A |
| EPS Growth | ★ 12.56 | N/A |
| EPS | ★ 6.55 | 0.07 |
| Revenue | ★ $5,833,958,000.00 | $4,591,000,000.00 |
| Revenue This Year | $11.74 | $5.77 |
| Revenue Next Year | $10.04 | $4.96 |
| P/E Ratio | ★ $26.10 | $322.70 |
| Revenue Growth | ★ 14.40 | 3.08 |
| 52 Week Low | $148.73 | $8.02 |
| 52 Week High | $205.11 | $23.70 |
Technical Indicators
Market Signals| Indicator | TXRH | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 50.94 | 55.61 |
| Support Level | $165.70 | $20.95 |
| Resistance Level | $178.68 | $23.70 |
| Average True Range (ATR) | 4.06 | 0.75 |
| MACD | 0.81 | 0.06 |
| Stochastic Oscillator | 57.11 | 59.45 |
Price Performance
Historical ComparisonAbout TXRH Texas Roadhouse Inc.
Texas Roadhouse Inc is a restaurant company operating predominantly in the casual dining segment. The company manages its restaurant and franchising operations by concept and, as a result, has identified Texas Roadhouse, Bubba's 33, Jaggers, and retail initiatives as separate operating segments. In addition, it has identified Texas Roadhouse and Bubba's 33 as reportable segments. Maximum revenue for the company is generated from the Texas Roadhouse segment, which is a moderately priced, full-service, casual dining restaurant concept offering steaks, a selection of ribs, seafood, chicken, pork chops, pulled pork, vegetable plates, and an assortment of hamburgers, salads, and sandwiches.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.